If they were waiting for these results, they wouldn’t have had to wait until the conference as they would have already seen the results under an NDA just like the company touted was occurring back in 2021 …. they could be negotiating a deal with these parties with these additional results or they could have all walked away like the “several potential partners” appear to have done since 2021 given no DEP license deal to date has surfaced ?
Maybe Starpharma are simply asking for too much money in the DEP negotiations and so no one is interested ?
GLTAH
ASCO Presentations 2024, page-28
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.007(7.14%) |
Mkt cap ! $43.29M | |||
| Open | High | Low | Value | Volume |
| 9.5¢ | 10.5¢ | 9.5¢ | $8.154K | 83.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5102 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 124847 | 3 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |